Certara President Patrick F. Smith steps down, moves to senior advisory role

Certara, Inc.

Dr. Patrick F. Smith stepped down as President, Certara Drug Development Solutions, effective March 3, 2025.
Smith remains employed at Certara in a senior advisory and scientific capacity.
No replacement for the President role was announced in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Patrick F. Smith

President, Certara Drug Development Solutions

CERT · Certara, Inc.

Effective: 2025-03-03
Filed: March 5, 2025, 6:59 PM ET

On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Patrick F. Smith departed as President, Certara Drug Development Solutions at Certara, Inc..

Action: stepped down
Role: President, Certara Drug Development Solutions

Exact text from the filing

On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.

View on SEC.gov

Certara, Inc. filing history →

Source: SEC EDGAR

accession 0001827090-25-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.